1. Home
  2. CVAC vs FMBH Comparison

CVAC vs FMBH Comparison

Compare CVAC & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • FMBH
  • Stock Information
  • Founded
  • CVAC 2000
  • FMBH 1865
  • Country
  • CVAC Germany
  • FMBH United States
  • Employees
  • CVAC N/A
  • FMBH N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • FMBH Major Banks
  • Sector
  • CVAC Health Care
  • FMBH Finance
  • Exchange
  • CVAC Nasdaq
  • FMBH Nasdaq
  • Market Cap
  • CVAC 764.4M
  • FMBH 853.8M
  • IPO Year
  • CVAC 2020
  • FMBH N/A
  • Fundamental
  • Price
  • CVAC $5.45
  • FMBH $39.43
  • Analyst Decision
  • CVAC Hold
  • FMBH Hold
  • Analyst Count
  • CVAC 3
  • FMBH 5
  • Target Price
  • CVAC $6.83
  • FMBH $44.00
  • AVG Volume (30 Days)
  • CVAC 2.2M
  • FMBH 81.9K
  • Earning Date
  • CVAC 08-14-2025
  • FMBH 07-31-2025
  • Dividend Yield
  • CVAC N/A
  • FMBH 2.44%
  • EPS Growth
  • CVAC N/A
  • FMBH 8.80
  • EPS
  • CVAC 0.87
  • FMBH 3.37
  • Revenue
  • CVAC $566,039,775.00
  • FMBH $321,695,000.00
  • Revenue This Year
  • CVAC N/A
  • FMBH N/A
  • Revenue Next Year
  • CVAC $24.04
  • FMBH $4.02
  • P/E Ratio
  • CVAC $6.31
  • FMBH $11.69
  • Revenue Growth
  • CVAC 787.60
  • FMBH 11.71
  • 52 Week Low
  • CVAC $2.37
  • FMBH $27.58
  • 52 Week High
  • CVAC $5.72
  • FMBH $43.86
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.07
  • FMBH 67.05
  • Support Level
  • CVAC $5.36
  • FMBH $38.83
  • Resistance Level
  • CVAC $5.45
  • FMBH $39.92
  • Average True Range (ATR)
  • CVAC 0.08
  • FMBH 1.08
  • MACD
  • CVAC -0.05
  • FMBH 0.28
  • Stochastic Oscillator
  • CVAC 58.00
  • FMBH 98.00

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

Share on Social Networks: